| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |